Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The Porcine Vaccines Market is vital to the veterinary care industry because it safeguards pig populations. Diseases, new technology, and global pork demand impact this industry.
The prevalence of pig illnesses affects the market. Swine flu, foot-and-mouth disease, and porcine reproductive and respiratory syndrome (PRRS) may be controlled using pig vaccines. Vaccine demand is driven by illness prevention.
Technology advances greatly impact markets. Recombinant DNA and better adjuvants make pig vaccinations safer and more effective. The quick speed of technology influences product development and market competition.
The global demand for pork impacts markets. The hog industry is expanding to fulfill pork demand. Pig populations need effective treatments to be healthy and productive. Global pork production changes impact the market.
Disease outbreaks and biosecurity affect the market. Due to their emphasis on health, farmers and pig farmers may purchase more medications when illnesses develop. Changing illness management influences medication usage and solution development.
Market functioning depends on regulatory responsibility. Pig immunizations are safe and effective when following veterinary vaccine standards. Companies that follow these criteria affect market trends and strength. This emphasizes product safety and quality.
Pig business growth alters marketplaces. Companies doing business abroad must cope with foreign diseases, laws, and cultures. Companies' initiatives to extend their businesses to satisfy pigs' worldwide healthcare demands effect competition and the market.
Partnerships between pig vaccination makers and research organizations effect market trends. Joint clinical investigations, study initiatives, and vaccine improvement efforts are common in partnerships. Research partnerships increase the market and determine competitiveness.
Farm finance and price impact market dynamics. Pig farmers must know hog medication prices and efficacy. Agriculture's limited finances and economic shifts impact consumers' buying choices, which affects the market.
The business's emphasis on pig health prevention rather than treatment affects the market. Porcupine vaccines reduce treatment needs and are helpful for preventive health care. This emphasis on protection influences product design and market demand.
New contagious illnesses provide commercial challenges and opportunities. Companies that respond quickly to emerging risks and develop novel illness treatments boost market growth. Changing preparatory efforts affect product quality and market competitiveness.
Adapting pig vaccinations to diverse breeds and production systems is a major industry development. Medicines operate better when tailored to certain pig groups. How fast corporations adapt to breed demands affects product preferences and expansion goals.
Porcine Vaccines Market Highlights:
Global Porcine Vaccines Market Overview
Porcine Vaccines Market Size was valued at USD 1.79 Billion in 2023. The Global Porcine Vaccines industry is projected to grow from USD 1.92 Billion in 2024 to USD 3.04 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.27% during the forecast period (2024 - 2032).
Industry News in Porcine Vaccines Market
June 2024: Boehringer Ingelheim has introduced the Ingelvac® PRRSFLEX vaccine, an advanced adjuvant technology designed to enhance immune response and provide extended protection against multiple PRRS virus strains, offering improved efficacy and safety in field conditions.
January 2024:Ceva Santé Animale has introduced the Vaxxitek® HVT+IBR marker vaccine for swine, providing protection against PRRS and other common porcine diseases. The vaccine uses a recombinant virus vector platform, enhancing herd health management and vaccine technology advancement.
The porcine vaccine denotes an administrative and clinical drug that helps improve swine health. These vaccines help to protect from pathogens, deadly viruses and bacteria. Due to vaccines, widespread diseases such as swine influenza, diarrhoea, and respiratory syndrome have been reduced.
The increase in the commonness of diseases in swine all over the globe acts as one of the main factors which are operating the growth of the porcine vaccines market. The continuous invention in the market to fulfil the customer demand and the rise in initiatives by the government to support stages of development of vaccines increase the market growth. The increasing focus on delivering vaccination services to properly use the swine vaccines to deal with bacteria or viruses further influences market growth. Moreover, the technological development, rise in population and increase in the number of generic drug producers positively impact the porcine vaccines market. Furthermore, the special designation from the regulatory authority extends profitable opportunities to the main market players in the predicted period of 2022 to 2029. The covid-19 pandemic had an important impact on the market. Considering this global challenge, the pharmaceutical industry has extended its research at an extraordinary pace. For example, the research and development unit of Boehringer Ingelheim Animal Health business was renamed Animal Health Global Innovation. It was given a new administrative structure based on disease and a system-centred R&D approach. This allows the company to bring modernisations in treatment and preventive veterinary therapies to the market.
Porcine Vaccines Market Segment Insights
The porcine vaccines market has been segmented into type, disease indication, and end user.
Porcine Vaccines Type Insights
By type, the market has been segmented into Inactivated vaccines, Live attenuated vaccines, Toxoid vaccines, Recombinant vaccines, Conjugate vaccines, DNA vaccines.
Porcine Vaccines Disease Indication Insights
On the basis of disease indication, the market has been segmented into PED (Porcine Epidemic Diarrhea), PRRS (Porcine Reproductive & Respiratory Syndrome), Swine influenza, Aujeszky's disease (AD), Porcine Circovirus Associated Disease (PCVAD) and others.
Porcine Vaccines End-User Insights
The market, by end user, has been segmented into Veterinary Hospitals and Hog Production Farm.
Porcine Vaccines Regional Insights
The porcine vaccines market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The porcine vaccines market in the Americas has further been segmented into North America and Latin America, with the North American market divided into the US and Canada.
The European porcine vaccines market has been segmented into Western Europe and Eastern Europe. The Western Europe porcine vaccines market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The porcine vaccines market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The porcine vaccines market in the Middle East & Africa has been segmented into the Middle East and Africa.
Regional Market Summary
Geographically, the Americas is anticipated to dominate the global porcine vaccines market owing to the rise in number of pig farms and rise in swine diseases such as PED (Porcine Epidemic Diarrhea), PRRS (Porcine Reproductive & Respiratory Syndrome), swine influenza etc. Moreover, rapid increase in contract farming and independent farming for pig cultivation is driving the growth of this market in this region. According to a report from National Hog Farmer, there were 71.7 million pigs in US hog farms as of June 2016.
Europe is expected to hold the second largest position in the global porcine vaccines market. The market growth in this region is attributed to increasing number of production units for swine and high consumption of pork meat.
The porcine vaccines market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region owing to initiatives by various government agencies, animal associations, and high growth opportunities for major key players for setting up their vaccine manufacturing plants in this region.
The Middle East & Africa has the lowest share of the global porcine market. Majority of the market of the region is anticipated to be held by the Middle East region owing to the growing government initiatives for the animal care sector.
Porcine Vaccines Market, by Key Players
- Bayer AG
- Bimeda, Inc.
- Boehringer Ingelheim International GmbH
- Ceva Sante Animale
- Eli Lilly and Company
- Merck & Co., Inc.
- Sanofi S.A.
- Vetoquinol S.A.
- Zoetis, Inc.
- PBS Animal Health
- Aptimmune
Porcine Vaccines Market Segmentation
Porcine Vaccines Type Outlook
- Inactivated vaccines
- Live attenuated vaccines
- Toxoid vaccines
- Recombinant vaccines
- Conjugate vaccines
- DNA vaccines
Porcine Vaccines Disease Indication Outlook
- PED (Porcine Epidemic Diarrhea)
- PRRS (Porcine Reproductive & Respiratory Syndrome)
- Swine influenza
- Aujeszky's disease (AD)
- Porcine Circovirus Associated Disease (PCVAD)
- Others
Porcine Vaccines End-user Outlook
- Veterinary Hospitals
- Hog Production Farm
Porcine Vaccines Regional Outlook
- Americas
- North America
- US
- Canada
- Latin America
- North America
- Europe
- Western Europe
- Germany
- France
- Italy
- Spain
- UK
- Rest of Western Europe
- Eastern Europe
- Western Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- The Middle East & Africa
- Middle East
- Africa
Recent Development
In the year 2021
The vaccine was created together and manufactured using CrisBio. This improved the rate of vaccine sales in the market.
Intended Audience
- Porcine vaccines manufacturers
- Porcine vaccines suppliers
- Private research laboratories
- Research and development (R&D) companies
- Market research and consulting service providers
- Government research laboratories
- Contract manufacturing organizations
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
